National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

CEP-701

 A drug being studied in the treatment of acute leukemias and some other types of cancer. It binds to a protein that is present on the surface of some types of cancer cells and stops them from dividing. CEP-701 is a type of receptor tyrosine kinase inhibitor and a type of indolocarbazole alkaloid. Also called lestaurtinib.



Previous Definitions:central nervous system prophylaxis, central nervous system sanctuary therapy, central nervous system tumor, central venous access catheter, CEP-2563 dihydrochloride
Next Definitions:cephalexin, cephalosporin, ceramide, cerebellar hemangioblastoma, cerebellopontine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov